Quote | Super Quote
IPO   |   IPO News   |   Listed IPO Information   |   Hot Listed IPO
Stock Code   IPO News IPO Timetable
IPO Detail
09886 叮噹健康
DINGDANG HEALTH
Listing Date2022/09/14
Listing Price12.000
 
Quote
  • 11.920 -0.240 (-1.974%)    Sink Below Listing Price
  • 15-min delayed, last update: 05/12/2022 18:00
Subscription Result
  • Subscription Rate
    7.20x
  • Guarantee One Lot Size
    10 lot
  • One Lot Success Rate
    11.22%
COMPANY PROFILE

Dingdang Health Technology Group is a service provider in providing express digital healthcare services in China, since its inception in 2014. It is operating on-demand pharmaceutical retail and medical consultation, primarily with online-to-offline solutions, including operations related to its online platforms, offline smart pharmacies and express delivery service.

The Group is a service provider in the digital retail pharmacy industry in China and ranked No. 3 in such industry by revenue in 2021 with a market share of 1.0%, according to the Frost & Sullivan Report. It is also the largest product and service provider in the on-demand digital pharmacy industry in China by revenue in 2021 with a market share of 6.8%

Its drug express service offering is mainly operated through online direct sales channel, in which the Group sells products directly to users. As of 23 Aug 2022, the Group has established a network of 351 smart pharmacies across 17 cities in China. It focuses on express delivery, on-demand digital pharmacies aim to provide last-mile delivery service for users to purchase medicines and usually deliver medicines within 30 minutes to users after orders placed.

BASIC INFORMATION
MarketHong Kong (Main Board)
Business NatureHealth Care
Major Business AreaChina
Board Lot500
GLOBAL OFFERING
No. of Offer Shares33.54M shares
No. of International Offer Shares30.18M shares
No. of HK Offer Shares3.35M shares
Offer Price$12.00
Stock Code9886
Sponsor(s)China International Capital Corporation Hong Kong Securities Limited, CMB International Capital Limited
Underwriter(s)China International Capital Corporation Hong Kong Securities Limited, CMB International Capital Limited, Futu Securities International (Hong Kong) Limited, Silverbricks Securities Company Limited
TIME TABLE
Application PeriodSep 01 (Thu) - noon, Sep 06 (Tue)
Price Determination Date--
Result Announcement DateOn or before Sep 13 (Tue)
Result Announcement DateOn or before Sep 13 (Tue)
Dealings in Shares commence onSep 14, 2022. (Wed)
Reallocation of Shares Offered
Times of HK Offer Shares Subscription15X - 50X50X - 100XOver 100X
% of total shares reallocated to HK Offer30%40%50%
Sales Statistics (HKD)
Offer Price$12.00
Capitalization16.10B
NAV / share ($)$-5.2 (Unaudited pro forma adj NAV / share)
Use Of Proceeds
Assuming the offer price being at HKD 12.00, the net proceeds raised would be HKD 341.60M, of which
45% : Business expansion such as the further development of smart pharmacy network, and enhancement of user growth and engagement
15% : Optimizing technology systems and operating platforms
10% : Upgrading services and business such as building professional structure of full-time doctors and pharmacists
20% : For potential investments and acquisitions or strategic alliances
10% : Working capital
Related Document
Remark: The above information is referenced from the prospectus.
  All data is calculated from the non- exercise rights(if applicable).
IPO Calculator
Name︰
--
--
--
Subscription --
Result Announcement --
Listing --
Offer Price︰--
Currency :
Listing Price :
Board Lot :
Admission Fee*
:
Subscribing Lot :
Subscribing Fee :

Subscribing Amount :
*Admission fees include brokerage of 1%, SFC transaction levy of 0.0027%, Stock Exchange trading fee of 0.005% and FRC transaction levy of 0.00015% (i.e. 1.0077% in total).
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2022 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.